Feb 21, 2019 - Disappointing data from Gilead Sciences and Sangamo weigh on investors, while one tiny stock challenges Allergan.
Feb 20, 2019 - Allergan (AGN) informs that it does not agree with the view of its key shareholder, Appaloosa, to separate the roles of CEO and board chairman.
Feb 19, 2019 - Corporate executives worried about workplace shootings are quietly installing gunfire-detection systems in U.S. offices and factories. Most don’t tell employees what the sensors are, for fear of alarming them.
Feb 15, 2019 - Allergan PLC (AGN) Files 10-K for the Fiscal Year Ended on December 31, 2018, Stocks: AGN, release date:Feb 15, 2019
Feb 14, 2019 - Teva's (TEVA) fourth-quarter earnings miss estimates while sales marginally beat expectations. Guidance for 2019 is lower than expected.
Feb 05, 2019 - Under pressure over rising drug prices, pharmaceutical companies are pushing a new defense: They’re not raising prices to make money or to cover research costs, but rather to pay a cut to middlemen in the supply chain.
Feb 05, 2019 - Allergan's (AGN) stock declines almost 4% after FDA approves Evolus' Jeuveau injection to treat frown lines, which can pose strong competition to Botox.
Jan 29, 2019 - AGN earnings call for the period ending December 31, 2018.
Jan 29, 2019 - Allergan Plc (NYSE:AGN) Q4 2018 Earnings Conference Call January 29, 2019 08:30 AM ET Company Participants Manisha Narasimhan - Investor Relations Brenton L. Saunders - Chairman, President & CEO W
Jan 29, 2019 - Allergan (AGN) beats fourth-quarter estimates for earnings and sales with Botox being the primary sales driver. The company provides full-year guidance for 2019.